Determination of HbA1c concentrations in patients with acute myocardial infarction: Comparison of the DCA 2000 device with the HPLC method

Diabetes and Metabolism

Volumn 31, Issue 3 I, 2005, Pages 290-294

  Hadjadj, S ^a   Duengler, F ^a   Barriere, M ^a   Mauco, G ^a   Coisne, D ^a   Warnier, F ^b   Sosner, P ^a   Torremocha, F ^a   Herpin, D ^a   Marechaud, R ^a  

^a POITIERS UNIVERSITY HOSPITAL   (France)

^b Bayer Diagnostics   (France)

Author keywords

Acute myocardial infarction; Diabetes; HbA1c; Screening

Indexed keywords

HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; DEVICE; DIAGNOSTIC ACCURACY; FEMALE; HEMOGLOBIN DETERMINATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; INTERMETHOD COMPARISON; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; RELIABILITY; SENSITIVITY AND SPECIFICITY; AUTOANALYSIS; BLOOD; BLOOD SAMPLING; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HOSPITAL PATIENT; METABOLISM; REGRESSION ANALYSIS;

AUTOANALYSIS; BLOOD GLUCOSE; BLOOD SPECIMEN COLLECTION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INPATIENTS; MYOCARDIAL INFARCTION; REGRESSION ANALYSIS;

EID: 21844478273     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1262-3636(07)70196-9     Document Type: Review

References (16)

1. Mukamal K, Nesto R, Cohen M, et al. Impact of diabetes on long-term survival after acute myocardial infarction. Diabetes Care, 2001, 24, 1422-1427.
2. Miettinen H, Lehto S, Salomaa V, et al. Impact of diabetes on mortality after the first myocardial infarction. Diabetes Care, 1998, 21, 69-75.
3. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med, 1998, 339, 229-234.
4. Oswald GA, Yudkin JS. Hyperglycaemia following acute myocardial infarction: the contribution of undiagnosed diabetes. Diabet Med, 1987, 4, 68-70.
5. Malmberg K, Ryden L, Efendic S, et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI Study): effects on mortality at 1 year. J Am Coll Cardiol, 1995, 26, 57-65.
6. Chantelau E, Meyer-Schwickerath R. Reversion of early worsening' of diabetic retinopathy by deliberate restoration of poor metabolic control. Ophthalmologica, 2003, 217, 373-7.
7. Kohner EM, Stratton IM, Aldington SJ, Holman RR, Matthews DR. Relationship between the severity of retinopathy and progression to photocoagulation in patients with Type 2 diabetes mellitus in the UKPDS (UKPDS 52). Diabet Med, 2001, 18, 178-84.
8. Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J, 2000, 21, 1502-13.
9. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron, 1976, 16, 31-41.
10. Bland J, Altman D. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet, 1986, (i), 307-310.
11. Hadjadj S, Coisne D, Mauco G, et al. Prognostic value of admission plasma glucose and HbA1c in acute myocardial infarction. Diabet Med, 2004, 21, 305-10.
12. Norhammar A, Tenerz A, Nilsson G, et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet, 2002, 359, 2140-4.
13. Malmberg K, Norhammar A, Wedel H, Ryden L. Glycometabolic state at admission: important risk marker in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long term results from the Diabetes and Insulin-Glucose in Acute Myocardial Infarction (DIGAMI) study. Circulation, 1999, 25, 2626-2632.
14. Miyazaki M, Kubo M, Kiyohara Y, et al. Comparison of diagnostic methods for diabetes mellitus based on prevalence of retinopathy in a Japanese population: the Hisayama Study. Diabetologia, 2004, 47, 1411-5.
15. Guerci B, for the DCA 2000 study group Multicentre evaluation of the DCA 2000 system for measuring glycated haemoglobin. Diabetes Metab, 1997, 23, 195-201.
16. 1c. Diabet Med, 1993, 10, 260-3.